< Back to companies
Epsilen Bio
Milano, Italy
Epsilen Bio is developing a transformative therapy known as Epigenetic Silencing to treat human diseases. Epsilen Bio's mission is to develop therapies for patients affected by underserved medical conditions, through stable genomic epigenetic silencing of genes involved in pathological processes.
Company Info
- Founded
- 2019
- Website
- www.epsilenbio.com/
Categories
Precision Medicine/Diagnostics
Disease Areas
Technologies
EpigeneticsGene TherapyBiotechnologyTargeted Therapeutics
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowWhat do you think of Epsilen Bio?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.